Literature DB >> 313476

Pathophysiological aspects of Hodgkin's disease.

D Huhn.   

Abstract

Hodgkin's disease is characterized by unique features setting it apart from other malignancies. Clinically, systemic symptoms are often prominent and spontaneous remissions may be seen. As major immunological aberrations, a reactive humoral response with hypergammaglobulinemia and a depression of cell-mediated immunity are observed. Pathologically, the diagnosis is based on the presence of pleomorphic morphology; this consists of an infiltrate of reactive inflammatory cells sometimes forming granulomatous lesions with or without varying numbers of the cells presumed to be malignant. The nature of these malignant cells remains undefined, with data supporting mainly B-cell, but also macrophage origin. Clear-cut evidence for monoclonality is available only in prognostically unfavourable histological forms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313476     DOI: 10.1007/bf01487818

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  30 in total

1.  Clonal growth of Hodgkin cells.

Authors:  W R Boecker; D K Hossfeld; W M Gallmeier; C G Schmidt
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Enzyme histochemistry of the cells in Hodgkin's disease and allied disorders.

Authors:  R F DORFMAN
Journal:  Nature       Date:  1961-06-03       Impact factor: 49.962

3.  Increased myeloid-associated enzymes in Epstein-Barr virus nuclear antigen--positive human cell lines exposed to butyric acid in vitro.

Authors:  J S Greenberger; A Karpas; P J Gans; H Neumann; W C Moloney
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

4.  Pathogenesis of Hodgkin's disease.

Authors:  S E Order; S Hellman
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

5.  Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.

Authors:  P A Ward; J L Berenberg
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

6.  [Immunglobulins G, A, M, and E in lymphogranulomatosis (author's transl)].

Authors:  C Steidle; A Fateh-Moghadam; R Lamerz; D Huhn; H Ehrhart
Journal:  MMW Munch Med Wochenschr       Date:  1976-04-16

7.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

8.  Cytochemical, ultrastructural and immunological studies of circulating Reed-Sternberg cells.

Authors:  F G Hayhoe; G F Burns; J C Cawley; J W Stewart
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

9.  The ultrastructure of the abnormal reticulum cells in Hodgkin's disease.

Authors:  I Carr
Journal:  J Pathol       Date:  1975-01       Impact factor: 7.996

10.  Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.

Authors:  Z Fuks; S Strober; H S Kaplan
Journal:  N Engl J Med       Date:  1976-12-02       Impact factor: 91.245

View more
  1 in total

1.  [Adenosine deaminase activity in Hodgkin's disease (author's transl)].

Authors:  G Müller; K Krug; W Krüger; V Richter; F Rassoul
Journal:  Klin Wochenschr       Date:  1982-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.